Comparative Clinical and Economic Analysis of Using SYSADOA Drugs Containing Chondroitin Sulphate or Influencing Its Biosynthesis in the Treatment of Patients With Stage II Knee Osteoarthritis

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology
doi 10.17749/2070-4909.2019.12.4.255-266

Related search